Connect with us

Tech

VEON Partners With Amdocs for New Digital Services for Uzbekistan and Kazakhstan

Published

on

ST. LOUIS and AMSTERDAM, Oct. 26, 2021 (GLOBE NEWSWIRE) — Amdocs (NASDAQ: DOX), a leading provider of software and services to communications and media companies, and VEON Ltd (NASDAQ and Euronext Amsterdam: VEON), a leading global provider of connectivity and internet services, announce that they have signed a seven-year agreement that will enable innovative digital services for VEON customers in Uzbekistan and Kazakhstan.
The agreement is expected to lay the foundation for VEON’s Beeline mobile operators in Uzbekistan and Kazakhstan to launch transformational digital services and personalised experiences. This will happen by deploying Amdocs’s microservices-based monetisation and commerce suites, using technology based on cloud-ready architecture.
VEON Group companies, through their unique digital operator strategies, serve their consumer (B2C) and enterprise (B2B) customers with advanced financial, entertainment and data analytics-based services. As of 30 June 2021, VEON Group, operating in 9 countries with 213.7 million subscribers served 18.8 million users with digital content and 19.4 million with digital financial services, while supporting tens of thousands of merchants by helping them to digitalise their customer reach and services. VEON Group companies also reach a total of 28 million mobile users through self-care mobile apps.
“VEON is embarking on a journey to be a world-leading digital operator,” explains Kaan Terzioglu, CEO of VEON Group. “The ability to innovate, provision and adapt the digital services we can offer our customers is at the core of this journey. Amdocs is …
Full story available on Benzinga.comRead More

Source Here: benzinga.com

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Tech

Mereo BioPharma’s Etigilimab/Opdivo Combo Achieves One Complete Response in Cervical Cancer

Published

on

Mereo BioPharma Group plc (NASDAQ: MREO) reported interim data from ACTIVATE Phase 1b/2 study of its anti-TIGIT antibody, etigilimab, in combination with Bristol Myers Squibb Co (NYSE: BMY) Opdivo (nivolumab) in select recurrent advanced/metastatic solid tumors.
As of the cut-off date, one complete response in cervical cancer, one partial response in ovarian cancer, and four …
Full story available on Benzinga.comRead More

Original Article: benzinga.com

Continue Reading

Tech

Canada Plastics Pact Welcomes 15 New Partners

Published

on

OTTAWA, Nov. 30, 2021 (GLOBE NEWSWIRE) — Canada Plastics Pact is excited to be welcoming 15 new Partners following last month’s release of it’s shared action plan to build a circular economy for plastics packaging in Canada. The new Partners announced today include leading consumer goods organizations, provincial and municipal governments, resin producers, recyclers, a bio-based plastics startup, one of Canada’s largest waste management companies, a new non-profit Producer Responsibility Organization and leading non-profit organizations from across the country.
Since the CPP launched in January 2021, the CPP has doubled in size to include 81 leading industry, NGO, and public sector organizations who together account for over a third of the plastics packaging in the market nationally. These Partners are working collaboratively towards ambitious 2025 targets to create a circular economy for plastics packaging in Canada where it stays in the economy and out of the environment. This has included the release of Roadmap to 2025: A shared action plan to build a circular economy for plastics …
Full story available on Benzinga.comRead More

Article: benzinga.com

Continue Reading

Tech

HealthRecon Connect Successfully Completes SOC 1(R) Type 1 Examination

Published

on

DALLAS, Nov. 30, 2021 (GLOBE NEWSWIRE) — HealthRecon Connect, leading revenue cycle management solutions provider to Healthcare Providers based in the US, reaffirmed its commitment to internal security controls by successfully completing the System and Organizational Controls SOC 1(R) Type 1 examination. The report independently audited by Stakes CPA, LLC, validates that HealthRecon’s infrastructure, controls, policies, and procedures meet and/or exceeded the SOC 1(R) Type 1 criteria as of July 1, …
Full story available on Benzinga.comRead More

Source Here: benzinga.com

Continue Reading

Trending

BaypointNews.com